These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7801739)

  • 1. Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Artesi C; Xiao B; Perucca E; Di Perri R
    Acta Neurol Scand; 1994 Aug; 90(2):130-2. PubMed ID: 7801739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy.
    Barcs G; Walker EB; Elger CE; Scaramelli A; Stefan H; Sturm Y; Moore A; Flesch G; Kramer L; D'Souza J
    Epilepsia; 2000 Dec; 41(12):1597-607. PubMed ID: 11114219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
    Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
    Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
    Mazzucchelli I; Onat FY; Ozkara C; Atakli D; Specchio LM; Neve AL; Gatti G; Perucca E
    Epilepsia; 2006 Mar; 47(3):504-9. PubMed ID: 16529613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
    McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial.
    French JA; Baroldi P; Brittain ST; Johnson JK;
    Acta Neurol Scand; 2014 Mar; 129(3):143-53. PubMed ID: 24359313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
    Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of oxcarbazepine and carbamazepine: a double-blind study.
    Reinikainen KJ; Keränen T; Halonen T; Komulainen H; Riekkinen PJ
    Epilepsy Res; 1987 Sep; 1(5):284-9. PubMed ID: 3504404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
    Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
    Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic drug monitoring of oxcarbazepine].
    Bouquié R; Dailly E; Bentué-Ferrer D;
    Therapie; 2010; 65(1):61-5. PubMed ID: 20205998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment.
    Friis ML; Kristensen O; Boas J; Dalby M; Deth SH; Gram L; Mikkelsen M; Pedersen B; Sabers A; Worm-Petersen J
    Acta Neurol Scand; 1993 Mar; 87(3):224-7. PubMed ID: 8475694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How is oxcarbazepine different from carbamazpine?].
    Schmidt D; Elger CE
    Nervenarzt; 2004 Feb; 75(2):153-60. PubMed ID: 14770287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
    Tartara A; Galimberti CA; Manni R; Morini R; Limido G; Gatti G; Bartoli A; Strada G; Perucca E
    Br J Clin Pharmacol; 1993 Oct; 36(4):366-8. PubMed ID: 12959317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.